DAVID GRAHAM to Cyclooxygenase 2
This is a "connection" page, showing publications DAVID GRAHAM has written about Cyclooxygenase 2.
Connection Strength
0.303
-
Editorial: gastrointestinal safety of COX-2 selective and nonselective NSAIDs-the impact of the PRECISION trial. Authors' reply. Aliment Pharmacol Ther. 2018 06; 47(11):1546-1547.
Score: 0.138
-
Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Aliment Pharmacol Ther. 2004 May 15; 19(10):1051-61.
Score: 0.052
-
NSAIDs, Helicobacter pylori, and Pandora's Box. N Engl J Med. 2002 Dec 26; 347(26):2162-4.
Score: 0.047
-
Helicobacter pylori infection and the use of NSAIDs. Best Pract Res Clin Gastroenterol. 2001 Oct; 15(5):775-85.
Score: 0.044
-
Cyclooxygenase expression during Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci. 2003 Nov; 48(11):2139-46.
Score: 0.013
-
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. 1999 Nov 24; 282(20):1921-8.
Score: 0.010